Europe Cell Culture Market

The Europe cell culture market is anticipated to reach USD 14.23 billion by 2030 from USD 8.50 billion in 2025, at a CAGR of 10.8% during the forecast period. Major factors supporting growth in the Europe cell culture market include a strong biopharmaceutical and biologics manufacturing base, along with increasing R&D investment in cell & gene therapy, vaccines, and advanced therapeutics.

The Europe cell culture market is consolidated. Prominent players in the Europe cell culture market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Eppendorf SE (Germany), Lonza (Switzerland), and Getinge AB (Sweden), among others.

To know about the assumptions considered for the study download the pdf brochure

In April 2025, Sartorius acquired MatTek, a leading developer and manufacturer of 3D microtissue models, from BICO Group AB (Sweden). This acquisition will advance Sartorius’ cell culture portfolio.

Thermo Fisher Scientific Inc. (US) has a strong presence in the Europe cell culture market, offering a comprehensive portfolio of cell culture media, sera, reagents, and single-use technologies that support research, process development, and commercial bioproduction. The company serves a broad customer base, including pharmaceutical and biotechnology companies, CROs, CMOs, and academic research institutes. Its integrated bioprocessing capabilities, robust regional manufacturing and distribution infrastructure, and continued investments in advanced cell culture systems for biologics, vaccines, and cell & gene therapy manufacturing reinforce its leadership position in the European market. 

Merck KGaA (Germany) offers a wide range of cell culture products, including media, sera, supplements, and reagents, serving research, bioprocessing, and clinical applications. These products are widely used in biopharmaceutical manufacturing. The company has a strong international presence, with a broad distribution network and established relationships with research institutes and biotechnology and pharmaceutical companies worldwide. Additionally, Merck focuses on innovation in chemically defined and serum-free media, supporting scalability and regulatory compliance for advanced biologics and cell and gene therapy manufacturing.

Sartorius AG (Germany) is a key player in Europe cell culture market, providing cell culture media, bioprocess solutions, and single-use systems primarily for upstream biopharmaceutical manufacturing and process development. The company is widely adopted by biotech and pharmaceutical manufacturers across Europe for scalable, GMP-compliant production workflows. A strong focus on innovation in single-use bioprocessing, automation, and solutions tailored for cell and gene therapy, along with strategic collaborations and capacity expansions, supports Sartorius’s sustained growth in the Europe cell culture market.

Market Ranking

The Europe cell culture market is consolidated, with global suppliers gaining share through broad consumables portfolios and reliable supply. Thermo Fisher Scientific is among the market leaders, anchored by its Gibco cell culture media, reagents, supplements, and sera, along with custom media and bioproduction support that serve both research and regulated manufacturing workflows. Merck KGaA is another major force, supported by its extensive portfolio of chemically defined media, sera, and reagents, a strong European manufacturing presence, and deep integration across upstream bioprocessing for biologics and advanced therapies. Sartorius holds a leading position through its focus on upstream cell culture and bioprocess solutions, including scalable, GMP-compliant media and single-use platforms that support the production of biologics and cell & gene therapies. Across European end users, purchasing decisions increasingly favor consistency, regulatory documentation, ease of use, and scalable workflows, keeping consumables and platform-related repeat demand at the center of competition.

Related Reports:

Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com